What this deck covers
This deck focuses on Pharmacokinetic Parameters, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Study Pharmacokinetic Parameters in NAPLEX with focused flashcards that help you recognize the idea, recall the key rule, and apply it in practice-style prompts.
0% Complete
State the formula for half-life in terms of volume of distribution and clearance.
Tap card or press Space to flip
t21=CL0.693×V. Half-life integrates volume of distribution and clearance, using the natural log of 2 to express time for 50% elimination.
How well did you know it?
Card 1 / 25
Space to flip · ← / → to move · once flipped, → Got it · ← Still learning
This deck focuses on Pharmacokinetic Parameters, giving you a quick way to review the definitions, rules, and examples that matter most for NAPLEX.
Work through these flashcards in short sessions. Try to answer each prompt before flipping the card, then revisit any cards you miss until the explanation feels automatic.
Answer: t21=CL0.693×V. Half-life integrates volume of distribution and clearance, using the natural log of 2 to express time for 50% elimination.
Answer: t21=k0.693. Half-life is derived from the natural log of 2 divided by the elimination rate constant for first-order processes.
Answer: Apparent volume relating amount in body to plasma concentration. Volume of distribution is a proportionality constant linking the total drug amount in the body to its plasma concentration.
Answer: CL=k×V. Clearance equals the product of the elimination rate constant and volume of distribution in a one-compartment model with first-order kinetics.
Answer: CL=50500=10 L/h. Clearance is dose divided by AUC, reflecting elimination efficiency for IV administration.
Answer: Fraction of drug eliminated per unit time. The elimination rate constant represents the proportion of drug removed per unit time in first-order kinetics.
Answer: LD=FCtarget×V. Loading dose achieves target concentration rapidly by accounting for volume of distribution and bioavailability.
Answer: Ct=C0×e−kt. Concentration declines exponentially from initial value based on the elimination rate constant in a one-compartment model.
Answer: Fraction of administered dose reaching systemic circulation unchanged. Bioavailability quantifies the extent of unchanged drug entering systemic circulation relative to the administered dose.
Answer: Area under the plasma concentration–time curve. AUC measures total systemic drug exposure by integrating plasma concentration over time.
Answer: R=1−e−kτ1. The accumulation factor accounts for drug buildup at steady state based on elimination rate and dosing interval.
Answer: Clearance. For IV dosing, AUC is inversely proportional to clearance, which governs the rate of drug elimination.
Answer: V=CpAmount in body. Volume of distribution is calculated as the ratio of drug amount in the body to its plasma concentration at equilibrium.
Answer: C0Ct=e−kt. In first-order elimination, the fraction of drug remaining decays exponentially with time and rate constant.
Answer: Css,avg=CL×τF×Dose. Average steady-state concentration balances absorbed dose against clearance over the dosing interval.
Answer: t21=0.20.693=3.465 h. Half-life equals the natural log of 2 divided by the elimination rate constant in first-order elimination.
Answer: V=10400=40 L. Volume of distribution is dose divided by initial concentration after IV bolus in a one-compartment model.
Answer: V=C0Dose. After an IV bolus, volume of distribution equals the dose divided by the extrapolated initial plasma concentration.
Answer: Dose rate=FCL×Css. Maintenance dose rate sustains steady-state concentration by matching clearance adjusted for bioavailability.
Answer: MD=FCL×Css,avg×τ. Maintenance dose ensures average steady-state concentration by incorporating clearance, interval, and bioavailability.
Answer: Volume of plasma cleared of drug per unit time. Clearance quantifies the efficiency of drug removal by measuring the plasma volume from which the drug is completely eliminated per unit time.
Answer: CL=AUCDose. For intravenous dosing, clearance is the ratio of dose to the area under the concentration-time curve, reflecting total drug exposure.
Answer: Approximately 4 to 5 half-lives. Steady state is achieved when input equals output, typically after 4-5 half-lives in first-order kinetics.
Answer: k=6 h0.693=0.1155 h−1. The elimination rate constant is the natural log of 2 divided by half-life for first-order kinetics.
Answer: F=AUCIV×DoseEVAUCEV×DoseIV. Bioavailability compares AUCs normalized by doses between extravascular and IV routes to assess absorption efficiency.